Trial Profile
The Influence of Inhaled Nitric Oxide on Oxygen Saturation of Patients With COPD and IPF During Six Minute Walk Test.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Dec 2021
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Chronic obstructive pulmonary disease; Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 20 May 2020 Planned number of patients changed from 100 to 50 as per preliminary results presented at the 116th International Conference of the American Thoracic Society
- 20 May 2020 Preliminary results (n=13) presented at the 116th International Conference of the American Thoracic Society
- 22 Mar 2019 New trial record